Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

Stock analysts at HC Wainwright lifted their FY2025 earnings per share estimates for shares of Corvus Pharmaceuticals in a ...

Star charts show Corvus appearing in the southeast night sky during mid-March. It will make its way across the southern skies through the summer.

Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

Corvus Energy, Bergen, Norway, recently announced that it has received type approval from Lloyd’s Register (LR) for its ...

Insiders who purchased Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shares in the past 12 months are unlikely to ...

Corvus Pharmaceuticals Inc. (($CRVS)) has held its Q4 earnings call. Read on for the main highlights of the call. The recent earnings call of ...

Honeywell (Nasdaq: HON) has announced that its SwiftDecoder barcode-decoding software will be integrated into Corvus Robotics ...

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Corvus Energy, Bergen, Norway, announced its Dolphin NxtGen Energy marine battery system has received type approval from ...